Skip to content

Opening book details…

About this Medicine article

NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials by Kapacee, Zainul Abedin; Knox, Jennifer J.; Palmer, Daniel; Blagden, Sarah P.; Lamarca, Angela; Valle, Juan W.; McNamara, Mairéad G. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Kapacee, Zainul Abedin; Knox, Jennifer J.; Palmer, Daniel; Blagden, Sarah P.; Lamarca, Angela; Valle, Juan W.; McNamara, Mairéad G.
Publisher
Springer US; Springer-Verlag; Humana Press, Inc.; Springer Science and Business Media LLC (ISSN 1357-0560)
Published
2020
Field
Medicine (Health Sciences)

More by Kapacee, Zainul Abedin; Knox, Jennifer J.; Palmer, Daniel; Blagden, Sarah P.; Lamarca, Angela; Valle, Juan W.; McNamara, Mairéad G.

Browse all works by Kapacee, Zainul Abedin; Knox, Jennifer J.; Palmer, Daniel; Blagden, Sarah P.; Lamarca, Angela; Valle, Juan W.; McNamara, Mairéad G.